Pharmacotherapy for obsessive-compulsive disorder.

  title={Pharmacotherapy for obsessive-compulsive disorder.},
  author={Darin D. Dougherty and Scott L. Rauch and Michael A. Jenike},
  journal={Journal of clinical psychology},
  volume={60 11},
Pharmacotherapeutic options for obsessive-compulsive disorder (OCD) have expanded over the past half-century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the first-line pharmacotherapy for OCD. High dosages and long trials of the SRIs are needed for adequate treatment of OCD. The use of SRIs for the treatment of OCD is reviewed, then other pharmacotherapeutic treatment options, including SRI… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 21 extracted citations

Neuronal Glutamate Transporters Control Dopaminergic Signaling and Compulsive Behaviors.

The Journal of neuroscience : the official journal of the Society for Neuroscience • 2018
View 2 Excerpts

Open-Label Study of Duloxetine for the Treatment of Obsessive-Compulsive Disorder

The international journal of neuropsychopharmacology • 2015
View 1 Excerpt


Publications referenced by this paper.
Showing 1-10 of 12 references

Stereotactic cingulotomy.

Neurosurgery clinics of North America • 2003
View 1 Excerpt

Novel pharmacological treatments of OCD

W. A. Hewlett
View 1 Excerpt

Similar Papers

Loading similar papers…